01—Abstract
Summary
Summary of the 8-K filed August 7, 2026. Cited figures are marked; the original filing is the authoritative source.
Flex Ltd. (FLEX) held its 2026 Annual General Meeting on August 5, 2026, where shareholders re-elected all nine director nominees and re-appointed Deloitte & Touche LLP as the independent auditor for the 2027 fiscal year.
The meeting also saw the approval, on an advisory basis, of executive compensation and a general authorization for the Board of Directors to allot and issue Ordinary Shares. Crucially for investors, shareholders approved the renewal of the Share Purchase Mandate, allowing Flex to acquire up to 20%a of its outstanding Ordinary Shares.
Following this shareholder approval, the Company announced that its Board of Directors has authorized management to continue its share repurchase plan, with an aggregate amount not to exceed $2.0 billionb. These repurchases will be executed in the open market, subject to market conditions and regulatory compliance, and do not commit the company to a specific number of shares.
02—Key points
Key Highlights
- Re-election of all nine director nominees by shareholders.
- Re-appointment of Deloitte & Touche LLP as independent auditor for FY2027.
- Shareholder approval, on a non-binding, advisory basis, of executive compensation.
- Approval of a general authorization for the Board of Directors to allot and issue Ordinary Shares.
- Renewal of the Share Purchase Mandate, permitting the company to acquire up to 20% of its outstanding Ordinary Shares.
- Board of Directors has authorized management to continue share repurchases up to an aggregate amount of $2.0 billion.
- Share repurchases will be made in the open market, subject to market conditions and regulatory compliance.
03—Questions
Frequently Asked Questions
What is the significance of the Share Purchase Mandate renewal?
The renewal of the Share Purchase Mandate is significant because it grants the Company's Board of Directors the authority to purchase or acquire up to 20% of Flex Ltd.'s issued and outstanding Ordinary Shares. This signals a potential return of capital to shareholders through buybacks and can support the company's stock price.
What is the total value of the authorized share repurchase program?
Following shareholder approval of the Share Purchase Mandate, the Board of Directors has authorized management to continue its share repurchase plan for an aggregate amount not to exceed $2.0 billion. The actual number of shares repurchased will depend on market conditions and other factors.
Are the executive compensation approvals binding?
No, the approval of the compensation of the Company's named executive officers was on a non-binding, advisory basis. This means shareholders expressed their opinion, but the Board of Directors is not legally obligated to implement the approved compensation structure.
What is the purpose of the general authorization for the Board to allot and issue Ordinary Shares?
This authorization allows the Board of Directors the flexibility to issue new Ordinary Shares. This can be used for various corporate purposes, such as raising capital through equity offerings, employee stock option plans, or for acquisitions, giving the company strategic options.
04—Continue